CERS (Cerus Corporation) Stock Financials & Earnings

CERSCerus Corporation

Mkt Cap$358M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$206M

Net Income (TTM)-$16M

EPS (TTM)-$0.08

Free Cash Flow (TTM)$9M

Gross Margin54.5%

Op. Margin-4.2%

Net Margin-7.6%

FCF Margin4.1%

P/S Ratio (TTM)1.7x

P/E Ratio (TTM)—

YoY Rev Growth+14.3%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$31M	$17M	-$14M
Q2 23	$39M	$21M	-$12M
Q3 23	$40M	$22M	-$5M
Q4 23	$47M	$26M	$976K
Q1 24	$38M	$21M	-$8M
Q2 24	$45M	$25M	-$4M
Q3 24	$46M	$26M	-$961K
Q4 24	$51M	$27M	-$1M
Q1 25	$43M	$25M	-$6M
Q2 25	$52M	$29M	-$3M
Q3 25	$53M	$28M	$1M
Q4 25	$58M	$30M	-$641K

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Product
Q1 25	$43M

Revenue by Geography

Quarter	Europe Middle East And Africa	North America	Other
Q1 23	$14M	$17M	$328K
Q2 23	$14M	$24M	$843K
Q3 23	$14M	$26M	$175K
Q1 24	$13M	$25M	$178K
Q2 24	$14M	$31M	$558K
Q3 24	$14M	$32M	$696K
Q1 25	$12M	$31M	$427K
Q2 25	$17M	$35M	$547K
Q3 25	$17M	$35M	$923K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$28M	$67M	$95M
Q2 23	$21M	$64M	$85M
Q3 23	$17M	$62M	$79M
Q4 23	$12M	$54M	$66M
Q1 24	$21M	$52M	$72M
Q2 24	$12M	$59M	$71M
Q3 24	$22M	$54M	$76M
Q4 24	$20M	$60M	$80M
Q1 25	$19M	$61M	$81M
Q2 25	$16M	$62M	$78M
Q3 25	$16M	$63M	$79M
Q4 25	$20M	$63M	$83M

Shares Outstanding

Revenue Per Employee

Revenue / Employee